Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7M Buy
99,018
+12,632
+15% +$946K 0.03% 434
2025
Q4
$6.83M Buy
86,386
+27,900
+48% +$2.21M 0.04% 396
2025
Q3
$4.82M Buy
58,486
+10,830
+23% +$852K 0.03% 432
2025
Q2
$3.83M Buy
47,656
+17,153
+56% +$1.32M 0.03% 444
2025
Q1
$2.42M Buy
30,503
+862
+3% +$71.7K 0.03% 476
2024
Q4
$2.44M Buy
29,641
+11,530
+64% +$959K 0.03% 432
2024
Q3
$1.49M Buy
18,111
+8,318
+85% +$621K 0.03% 434
2024
Q2
$687K Buy
9,793
+6,907
+239% +$493K 0.03% 440
2024
Q1
$214K Sell
2,886
-329
-10% -$22.9K 0.03% 444
2023
Q4
$213K Buy
+3,215
New +$201K 0.05% 264
2023
Q1
Sell
-2,869
Closed -$208K 188
2022
Q4
$208K Sell
2,869
-600
-17% -$43K 0.1% 163
2022
Q3
$211K Sell
3,469
-200
-5% -$12.8K 0.12% 157
2022
Q2
$230K Buy
+3,669
New +$243K 0.13% 154
2020
Q4
Sell
-12,305
Closed -$457K 149
2020
Q3
$457K Buy
12,305
+20
+0.2% +$759 0.46% 57
2020
Q2
$449K Sell
12,285
-565
-4% -$19.7K 0.54% 51
2020
Q1
$393K Buy
12,850
+5,567
+76% +$247K 0.61% 51
2019
Q4
$371K Buy
7,283
+1,057
+17% +$51K 0.44% 77
2019
Q3
$294K Buy
6,226
+1,733
+39% +$82.6K 0.38% 95
2019
Q2
$223K Buy
+4,493
New +$211K 0.31% 113

Other funds holding MET

&Partners's MET Position: Q1 2026 in Review

&Partners increased its MetLife (MET) stake by 15% in Q1 2026, buying an estimated $946K and bringing the position to 99,018 shares worth $7M. The position accounts for 0.03% of the portfolio, ranked #434.

&Partners first reported a position in MET in Q2 2019 and has held it in 19 quarters since. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • &Partners held 99,018 shares of MetLife worth $7M as of Q1 2026.
  • &Partners bought 12,632 MetLife shares in Q1 2026, an estimated $946K.
  • MetLife made up 0.03% of &Partners's portfolio in Q1 2026, its #434 holding.
  • &Partners first reported a position in MetLife in Q2 2019 and has held it in 19 quarters since.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.